{
    "nct_id": "NCT04824027",
    "official_title": "Predicting Response to Neoadjuvant Chemotherapy Using Harmonic Motion Imaging in Women With Breast Cancer",
    "inclusion_criteria": "* Women age ≥18\n* Deemed eligible to receive neoadjuvant systemic therapy as per the treating physician, with the dose and schedule deemed appropriate by the treating physician.\n* Any stage invasive breast cancer provided the primary breast tumor size is ≥ 4 mm\n\nExclusion criteria:\n\n* Patient is pregnant or lactating\n* Presence of breast implants\n* History of laser or radiation therapy to the affected breast\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}